Concepedia

Ruud Ruiter

RR

7

Publications

386

Citations

7

H-Index

2019

Active since

Affiliations

Queen Mary University of London(Current)

Amsterdam UMC Location Vrije Universiteit Amsterdam

Sun Pharma Advanced Research (India)

University Medical Center Utrecht

Utrecht University

Ruud Ruiter is an author at Queen Mary University of London specializing in tumor biology, medicine, and cell biology.

ORCID

Top concepts

Publications per year

2019–2023

7

Publications

7

Combined CD28 and 4-1BB Costimulation Potentiates Affinity-tuned Chimeric Antigen Receptor–engineered T Cells

Esther Drent, Renée Poels, Ruud Ruiter et al. · Clinical Cancer Research · 2019 · 168 citations · Full text

Combining a CAR and a chimeric costimulatory receptor enhances T cell sensitivity to low antigen density and promotes persistence

Afroditi Katsarou, Maria Sjöstrand, Jyoti Naik et al. · Science Translational Medicine · 2021 · 114 citations · Full text

Liposomal dexamethasone inhibits tumor growth in an advanced human-mouse hybrid model of multiple myeloma

Anil K. Deshantri, Marcel H.A.M. Fens, Ruud Ruiter et al. · Journal of Controlled Release · 2019 · 36 citations · Full text

, , +6

CD38-specific Chimeric Antigen Receptor Expressing Natural Killer KHYG-1 Cells: A Proof of Concept for an “Off the Shelf” Therapy for Multiple Myeloma

Arwen Stikvoort, J. van der Schans, Subhashis Sarkar et al. · HemaSphere · 2021 · 23 citations · Full text

Polymeric micelles loaded with carfilzomib increase tolerability in a humanized bone marrow-like scaffold mouse model

Aida Varela-Moreira, Demian van Straten, Heleen F. van Leur et al. · International Journal of Pharmaceutics X · 2020 · 20 citations · Full text

Rows per page

1–5 of 7